A recent study published in JAMA Network Open highlights significant disparities in travel-time access to proton beam therapy (PBT) for cancer treatment across the contiguous United States. Proton beam therapy,…
Congressional Updates Doc Fix Signed Into Law A “mini-bus” federal funding package signed into law March 9 included the “Doctor Fix,” mitigating Medicare physician payment cuts by 1.68% effective March…
Virginia Attorney General Jason S. Miyares in December issued an opinion confirming that insurers in the Commonwealth are prohibited from denying coverage for proton therapy for cancer treatment when the…
Cancer is a disease where the passage of time can make a difference in treatment outcomes. Recent research underscores the reality that for cancer patients, each week of delay in…
Esophageal cancer incidence in the United States has been on the rise over the past few decades. The American Cancer Society's statistics reveal that in 2022, there were an estimated…
The recent ProPublica article, "Big Insurance Met Its Match When It Turned Down a Top Trial Lawyer’s Request for Cancer Treatment," sheds light on the issue of insurance denials for…
The National Association for Proton Therapy celebrates Coach Ron's remarkable journey, from proton therapy patient to being awarded the prestigious CSC Founders Award for his commitment to making a difference…
In early 2023, the National Cancer Institute (NCI) in partnership with the U.S. Department of Health and Human Services (HHS) released the National Cancer Plan, a guide the nation’s…
Input from NAPT critical in the formulation of revised treatment and coverage guidelines, ongoing stakeholder dialogue required for more frequent updates NAPT applauds revised guidelines for proton therapy approved…
The cost-value argument for expanding proton therapy coverage It may sound counterintuitive, but evidence suggests proton therapy for some indications costs less in total than conventional radiotherapy. Although the treatment is…
